Entheon Biomedical Corp. (CSE:ENBI)
Canada
· Delayed Price · Currency is CAD 0.100
0.00 (0.00%)
Dec 18, 2025, 3:06 PM EST
Entheon Biomedical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
1.39M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Universal Ibogaine | 2.06M |
| Appili Therapeutics | 206.31K |
| ASEP Medical Holdings | 296.77K |
| Waverley Pharma | 1.51M |
| Restart Life Sciences | -28.35K |
Entheon Biomedical News
- 3 months ago - Entheon Announces Execution of Business Combination Agreement with Nutravisor - Newsfile Corp
- 4 months ago - Entheon Announces Letter of Intent with Nutravisor Inc. - Newsfile Corp
- 1 year ago - Entheon Announces Change of Directors - Newsfile Corp
- 1 year ago - Entheon Issues Incentive Stock Options - Newsfile Corp
- 1 year ago - Entheon Announces Termination of Mentis AI Agreement - Newsfile Corp
- 1 year ago - Entheon Announces Agreement to Acquire Mentis AI - Newsfile Corp
- 4 years ago - Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets - Newsfile Corp
- 4 years ago - Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents - Newsfile Corp